Giovanni Ferrati

Giovanni Ferrati has extensive experience in the field of drug discovery and research. Giovanni worked as a Senior Scientist at Neuro-Bio Limited from May 2016 to October 2019, where they then transitioned to the role of drug discovery lead. Prior to this, they completed an Internship Program at Eli Lilly and Company from April 2013 to November 2013, where they focused on characterizing abnormal neuronal network activity and testing compounds for drug discovery. In addition, they held a Fellowship at the University of Nottingham from December 2017 to April 2018.

Giovanni Ferrati's education history begins in 2003 when they obtained a Bachelor's degree in Biotechnology from Università degli Studi di Firenze. Giovanni then pursued further education and obtained a Master's degree in Neuroscience from Università degli Studi di Torino between 2006 and 2008. Continuing their academic journey, from 2011 to 2015, they attended Instituto de Neurociencias de Alicante and successfully earned a Doctor of Philosophy (PhD) degree in Electrophysiology.